Exact Mass: 703.239
Exact Mass Matches: 703.239
Found 20 metabolites which its exact mass value is equals to given mass value 703.239,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tetrahydropteroyltri-L-glutamic acid
Tetrahydropteroyltri-L-glutamic acid (CAS: 4227-85-4), also known as (6S)-H4pteglu3, belongs to the class of organic compounds known as tetrahydrofolic acids and derivatives. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit (or a derivative thereof). Tetrahydropteroyltri-L-glutamic acid is a strong basic compound (based on its pKa). In humans, this compound is produced by the bacteria in the gut and may be found in feces or urine. Tetrahydropteroyltri-L-glutamica cid exists in all living species, ranging from bacteria to humans. Tetrahydropteroyltri-L-glutamic acid is an intermediate in the synthesis of methionine by bacteria. It is a substrate for the enzyme 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase which catalyzes the reaction 5-methyltetrahydropteroyltri-L-glutamic acid + L-homocysteine = tetrahydropteroyltri-L-glutamic acid + L-methionine. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Tetrahydrofolyl-[Glu](n)
Tetrahydrofolyl-[Glu](n) is involved in the folate biosynthesis pathway. Tetrahydrofolyl-[Glu](n) can be reversibly converted into Tetrahydrofolyl-[Glu](2) by folylpolyglutamate synthase [EC:6.3.2.17]. Tetrahydrofolyl-[Glu](n) can be irreversibly converted into tetrahydrofolate by gamma-glutamyl hydrolase [EC:3.4.19.9]. Sample structure image shows the case when n=3. Tetrahydrofolyl-[Glu](n) is involved in the folate biosynthesis pathway. Tetrahydrofolyl-[Glu](n) can be reversibly converted into Tetrahydrofolyl-[Glu](2) by folylpolyglutamate synthase [EC:6.3.2.17]. Tetrahydrofolyl-[Glu](n) can be irreversibly converted into tetrahydrofolate by gamma-glutamyl hydrolase [EC:3.4.19.9].
Antibiotic CC 1065
Brecanavir
2,2-{(1S,2S)-1,2-Cyclohexanediylbis[nitrilo(E)methylylidene]}bis [4,6-bis(2-methyl-2-propanyl)phenol] - trichlorochromium (1:1)
5?ˉ-O-(4,4?ˉ-DIMETHOXYTRITYL)-N2-PHENOXYACETYL-2?ˉ-DEOXYGUANOSINE
2-{Ethyl[3-({4-[(3-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyra zol-5-yl)amino]-7-quinazolinyl}oxy)propyl]amino}ethyl dihydrogen phosphate (2E)-2-butenedioate (1:1)
(6Z)-2,4-ditert-butyl-6-[[[(1R,2R)-2-[[(E)-(3,5-ditert-butyl-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]cyclohexyl]amino]methylidene]cyclohexa-2,4-dien-1-one,trichlorochromium
tert-butyloxycarbonyl-4-(tri-n-butylstannyl)-phenylalanine tetrafluorophenyl ester
Brecanavir
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
Antibiotic CC 1065
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D000080890 - Duocarmycins D009676 - Noxae > D000477 - Alkylating Agents
